Qualified Small Business Stock (QSBS) in 2026: How OBBBA's New Tiered §1202 Exclusion Lets Founders, Early Employees, and Angel Investors Shield Up to $15 Million in Capital Gains Tax-Free

Why 2026 Is the Inflection Point for QSBS — OBBBA's §1202 Overhaul Explained

For more than three decades, the architecture of Qualified Small Business Stock (QSBS) under Internal Revenue Code §1202 sat in roughly the same shape: a non-corporate taxpayer who held qualifying C-corporation stock for at least five years could exclude up to $10 million of gain (or 10× basis, whichever was greater) from federal capital gains tax, provided the issuer was a domestic C-corporation with $50 million or less of aggregate gross assets at issuance and conducted a "qualified trade or business." That stable picture changed on July 4, 2025, when President Trump signed the One Big Beautiful Bill Act (OBBBA) into law as Pub. L. 119-12. Section 70431 of the Act rewrote three of §1202's most consequential parameters in a single stroke — and 2026 is the first calendar year in which advisors, founders, employees, and angel investors are working with the new architecture in real client portfolios.[1, 10, 17]

Three structural changes drive the new architecture. First — a tiered exclusion replaces the old binary five-year rule. For QSBS acquired after July 4, 2025, holders may exclude 50 % of gain at three years, 75 % at four years, and 100 % at five years or more. Stock issued on or before July 4, 2025 remains under the old all-or-nothing five-year rule. Second — the per-issuer exclusion cap rises from $10 million to $15 million (or 10× basis, whichever is greater), with $7.5 million for married filing separately and inflation indexing beginning in 2027. Third — the gross-asset ceiling for "qualified small business" status rises from $50 million to $75 million, also indexed for inflation starting 2027. The Joint Committee on Taxation has scored the QSBS expansion at roughly $17.2 billion in additional revenue cost over the 2025-2034 budget window, with most of the score landing after 2030 because the new tiered holding period takes years to mature.[11, 1, 16, 18]

Why does 2026 matter specifically when OBBBA was signed in mid-2025? Three reasons. First, this is the first full filing year in which post-July-4-2025 QSBS shows up in client tax returns — typically as a Section 83(b) basis event for founder shares issued in late 2025 or as angel/seed-round investments funded after enactment. Second, the new 80 %-test compliance and "qualified trade" interpretive questions raised by §70431's expansion to higher-asset companies (the $75 million ceiling now reaches mid-stage Series B startups that previously aged out) are reaching CPA review in 2026 returns. Third, the IRS issued the first Form 8949 instructions reflecting the new tiered exclusion rules in late 2025, and tax preparers are now learning how to report partial QSBS exclusion gains using code "Q" in column (f) with the excluded portion entered as a negative number in column (g) — the same mechanic as before, but with three distinct exclusion percentages that must be tracked separately. To project what an extra $15 million in fully tax-free capital grows into over a 30-year retirement horizon, use our compound interest calculator.[13, 14, 7, 19]

The Five Statutory Tests Under §1202 (and the One That Trips Founders)

OBBBA changed three parameters, but it left the underlying eligibility architecture intact. To exclude any portion of gain under §1202, five tests must each be satisfied at the relevant points in time. They are: (1) the issuer must be a domestic C-corporation (not an S-corporation, partnership, LLC taxed as a partnership, or any non-U.S. entity) at all times from issuance through the holding period; (2) the holder must be a non-corporate taxpayer (an individual, trust, or pass-through partnership in which the partner is non-corporate) — corporations may not claim the §1202 exclusion; (3) the stock must be acquired by original issuance directly from the corporation, in exchange for money, property other than stock, or as compensation for services (purchases of stock from existing shareholders generally fail this test); (4) the stock must be held for the requisite holding period — three, four, or five years for post-OBBBA stock, or five years for pre-OBBBA stock — counted from the date of original issuance; and (5) during substantially all of the holder's holding period, the corporation must conduct a qualified trade or business and use at least 80 % of its assets in that active trade.[1, 20, 18]

The first three tests are usually satisfied at issuance and rarely fail later — the corporate form, the holder identity, and the original-issuance source are typically locked in by the time stock is delivered. The single test that routinely trips up founders and early employees is test #5: the active-business and 80 %-asset-use requirement. A C-corp that holds large cash reserves from a recent funding round, real estate not used in operations, or a passive investment portfolio can fail the 80 % test even while operating an apparently qualified line of business. The "substantially all" timing rule requires the test to be satisfied during essentially the entire holding period — not just at issuance and not just at sale — and the IRS examines compliance at multiple points. A single multi-quarter window in which 30 % of assets sit in a brokerage account earning passive yield can disqualify the entire stock issuance from §1202 treatment, retroactively.[1, 18, 20]

Test #1 also has a hidden trap: the C-corporation requirement applies continuously, which means a former S-corp that converted to C-corp status can never issue QSBS for the period before conversion, and pre-conversion S-corp shares cannot be retroactively re-classified as QSBS even after the conversion. Founders who incorporate as an LLC, operate for a year or two, then convert to a C-corp before institutional fundraising should understand that only stock issued after the C-corp conversion qualifies. Similarly, a corporation that briefly elects S-corp status and later revokes the election will generally have a "tainted" period during which any stock issued cannot qualify. The IRS interprets these rules strictly, and §1202 case law (notably Owen v. Commissioner, T.C. Memo 2012-21, on the active-business test) consistently holds that taxpayers bear the burden of proving every element of QSBS qualification at every relevant moment in time.[1, 20, 12]

The New Tiered Holding-Period Exclusion: 50 % / 75 % / 100 % at 3 / 4 / 5+ Years

Section 70431 of OBBBA inserted new subparagraphs into §1202(a) and (b) to create the tiered exclusion structure. For QSBS acquired after July 4, 2025: a holder who sells the stock at three years or more of holding period excludes 50 % of the eligible gain; at four years or more, the exclusion rises to 75 %; and at five years or more, the exclusion is the full 100 %. The "more" matters — the holding period must strictly exceed three or four years (not merely equal them) to land in the next tier, although the standard under §1223 is the issuance date plus the running holding-period clock, so a stock issued on August 1, 2025 first becomes eligible for the 50 % tier on August 2, 2028. Practitioners frequently summarize this as "three years and a day," "four years and a day," and "five years and a day."[1, 11, 18]

Critically, the un-excluded portion is not taxed at the regular long-term capital-gains rates (0 %, 15 %, or 20 %). It is taxed at a maximum federal rate of 28 %. This rule, which existed even under the pre-OBBBA architecture for the rare 50 %- and 75 %-exclusion regimes that applied to certain pre-2010 QSBS, comes from IRC §1(h)(4) and §1(h)(7): the unexcluded portion of QSBS gain is included in the holder's "28-percent rate gain" bucket, which is the same bracket as collectibles gain. Many founders mistakenly assume that selling at year three with a 50 % exclusion means paying 20 % on the other half — when the actual federal rate on the taxable half can be up to 28 %. Add the 3.8 % Net Investment Income Tax (NIIT) under §1411, and the marginal federal rate on the un-excluded half can reach 31.8 % for high earners.[5, 6, 18, 17]

The decision tree at year three or four is therefore non-trivial. Holding for one extra year converts taxable gain to fully tax-free gain, but the cost of holding is opportunity cost on the proceeds plus the risk that the issuer's active-business or 80 %-asset test could fail in the interim. A holder with $5 million of unrealized gain at year three faces this trade-off: sell now and exclude $2.5 million (paying up to 28 % + 3.8 % NIIT on the remaining $2.5 million ≈ $795,000 of federal tax), or wait two more years and exclude all $5 million. The breakeven required return on the $795,000 of saved tax over two years is roughly the same as a low-double-digit annualized return — only attractive if the holder has high conviction the issuer will remain qualified through year five and that the underlying stock will not lose more than ~20 % of value in the interim. For married-filing-separately couples whose per-issuer cap is halved to $7.5 million, and for pass-through holders close to AGI thresholds, the math becomes even more sensitive.[1, 8, 18]

The Per-Issuer Cap: $15 Million or 10× Basis (Whichever Is Greater)

Under §1202(b)(1), the gain that may be excluded by any one taxpayer with respect to any one issuing corporation is capped at the greater of two amounts: (A) $15 million (down to $7.5 million for a married-filing-separately spouse), or (B) ten times the aggregate adjusted basis of QSBS issued by that corporation that the taxpayer disposed of during the taxable year. The first cap was previously $10 million; OBBBA Section 70431(c) raised it to $15 million for QSBS acquired after July 4, 2025, and provided that beginning in 2027 the figure adjusts annually for inflation rounded to the nearest $1,000. The 10× basis rule is unchanged. The cap is per-taxpayer per-issuer per-lifetime — it is not an annual cap, and it does not aggregate across multiple issuing corporations. A taxpayer who has invested in five separate qualifying C-corps could potentially exclude up to $75 million in gains across the five (subject to each issuer's individual qualification).[1, 11, 18]

The 10× basis rule deserves more attention than it usually gets, because it is the dominant cap for early-stage founders and seed investors who acquire QSBS at very low cost. A founder who paid $1,000 for 10 million founder shares at incorporation has an aggregate adjusted basis of $1,000; ten times that figure is $10,000 — not nearly enough to make the 10× rule binding. However, an angel investor who paid $1 million for preferred stock in a Series A round has a basis of $1 million; ten times that is $10 million — already short of the new $15 million cap, so the $15 million figure binds. A late-stage employee who exercised stock options under §83 at a $5 million strike price has a basis of $5 million; ten times that is $50 million — well above the $15 million figure, so the 10× rule binds. Use the basis math to model your effective cap, not just the headline $15 million number.[1, 7, 20]

The 2027 inflation-adjustment provision is also more consequential than its line-item appearance suggests. Under §1202(b)(1) as amended, the $15 million cap (and the $7.5 million MFS variant) adjusts annually beginning in 2027, with adjustments rounded to the nearest $1,000. Even at modest 2 % CPI assumptions, the $15 million number would rise to roughly $15.3 million by 2027, $15.6 million by 2028, and $18 million by 2035. The $75 million asset threshold (covered separately in Section 5) follows the same indexing rule. For long-term planning, this index protects the cap's real value against inflation — a feature that did not exist for the prior $10 million figure, which had stood unchanged since 1993. To estimate how a fully-excluded gain near the new cap could grow if reinvested into a diversified taxable account over 10-30 years (factoring in tax drag from dividends and rebalancing), use our profit & loss calculator with appropriate after-tax inputs.[1, 18, 17]

The $75 Million Gross Asset Test and Why It Now Reaches Mid-Stage Startups

Section 70431(b) of OBBBA raised the "qualified small business" gross-asset ceiling under §1202(d)(1) from $50 million to $75 million for QSBS issued after July 4, 2025, with annual inflation indexing beginning in 2027. The test is two-pronged: at all times after August 9, 1993 and before the issuance, AND immediately after the issuance, the corporation's aggregate gross assets (computed on a cash-and-fair-market-value basis under §1202(d)(2)) must not exceed the threshold. For pre-OBBBA stock, the test stays at $50 million. The change has the largest practical impact on seed-extension, Series A, and early Series B startups — companies that were previously aging out of QSBS eligibility before completing their financing and now have an additional $25 million of room to issue QSBS-eligible equity to founders and employees.[1, 11, 18]

Two technical points trip up advisors. First — assets are measured at fair market value at the moment of contribution to the corporation, not at later book or carrying value. If a founder contributes intellectual property worth $20 million in exchange for stock, the corporation's gross assets immediately after the contribution include that $20 million IP at FMV — even if the IP carries a $0 tax basis. Second — the test applies at the moment of issuance and only that moment for the post-issuance prong; future asset growth above $75 million does not retroactively disqualify previously-issued QSBS. A startup that issues QSBS at a $30 million valuation in 2026, then grows to $300 million of assets by 2030, has not lost the QSBS status of the 2026 issuance — only future stock issuances after it crosses $75 million become disqualified. This "freeze at issuance" feature makes early-stage timing critical: a Series A round closed before the gross-asset crossover preserves QSBS for that batch even if subsequent rounds dilute or push the company past the threshold.[1, 20, 19]

Eligible vs. Excluded Trades: The "Qualified Trade or Business" Test

§1202(e)(3) defines a "qualified trade or business" by negative enumeration — meaning the statute lists what is excluded, and any trade or business not on the exclusion list is by default qualified. The excluded categories are: (A) any trade or business involving services in health, law, engineering, architecture, accounting, actuarial science, performing arts, consulting, athletics, financial services, brokerage services, or any business "the principal asset of which is the reputation or skill of one or more of its employees"; (B) any banking, insurance, financing, leasing, investing, or similar business; (C) any farming business (including raising or harvesting trees); (D) any business involving the production or extraction of products of a character with respect to which a deduction is allowable under §613 or §613A (mineral, oil, gas, geothermal, and timber depletion); and (E) any hotel, motel, restaurant, or similar business. SaaS, fintech-software, biotech, semiconductor, manufacturing, retail, and most other technology businesses are not on the exclusion list and therefore qualify.[1, 18, 20]

The "principal asset of which is the reputation or skill" exclusion is the most contentious in §1202 case law. The IRS and courts have applied it more narrowly than many practitioners expected. In Owen v. Commissioner (T.C. Memo 2012-21), the Tax Court held that an insurance brokerage failed §1202 because of the brokerage exclusion and the reputation/skill exclusion. But in numerous private letter rulings and informal guidance, the IRS has confirmed that technology product companies, even those built around the technical expertise of a small founding team, generally do not fail the reputation/skill test — the test is reserved for businesses where the customer relationship and revenue are tied to the personal performance of named individuals (consulting partnerships, doctors' offices, law firms, asset-management practices charging on AUM). A SaaS company whose product is licensed to many customers, even if engineered by a small team of "10× engineers," is selling a product, not personal services, and qualifies.[1, 18]

A useful diagnostic for entrepreneurs is the "if I left tomorrow, would the customer leave with me?" test. If your customers are buying a product and the answer is "no," you almost certainly qualify. If your customers are buying your personal expertise and the answer is "yes," you probably do not. The 80 % active-asset rule operates in parallel: even a clearly qualified product business can fail §1202 if it warehouses too much cash or non-business real estate. Compliance counsel typically advises QSBS-eligible startups to keep operating-account cash above the threshold needed for working capital but invested back into hiring, R&D, infrastructure, or marketing within reasonable timeframes — and to avoid concentrating excess cash in stocks, bonds, or non-operating real estate that could push the operational-asset ratio below 80 %. SBA size-standard guidance, while not directly binding for §1202, is sometimes used as a reference point for what constitutes "active" operations versus passive holding.[1, 22, 18]

§1045 Rollover: Deferring Gain by Reinvesting in Another QSB Within 60 Days

When a holder sells QSBS before reaching the relevant holding period — three years under the new tier or five years under the old rule — they may still preserve future tax benefits by rolling the proceeds into another qualifying small business under §1045. The §1045 rollover requires the holder to have owned the original QSBS for at least six months before the sale, to reinvest in replacement QSBS within 60 days of the sale, and to make an affirmative election on the tax return for the year of sale. The replacement stock must independently satisfy all five §1202 tests at its own issuance, with one critical mechanic: the holding period of the original QSBS tacks onto the replacement stock for the §1202 holding-period test, but the basis of the replacement is reduced by the rolled-over gain — preserving the gain for later realization.[2, 1, 12]

OBBBA did not change §1045 directly, but the introduction of the new 50%/75%/100% tiered exclusion creates two new strategic considerations. First, a holder approaching year three with strong conviction in a different opportunity can sell, take the 50 % exclusion, and roll the un-excluded portion into replacement QSBS — combining a partial exclusion with continued tax deferral on the rest. Second, the rollover is more attractive in scenarios where the original issuer has lost its qualified status (e.g., the company crossed the $75 million asset threshold or pivoted into an excluded trade) than in scenarios where the original issuer remains qualified — because rolling out of an issuer that has lost qualification protects against the risk of a fully-taxable disposition. Practitioners should also be aware that §1045 rollover does not extend the QSBS exclusion — only the gain that would have been excluded under the original holding period transfers to the replacement basis. The election is made on Form 8949 with code "R" and a worksheet attached.[2, 14, 18]

State Tax Conformity: Why California, Pennsylvania, and New Jersey Don't Honor §1202

A federal §1202 exclusion does not automatically translate into state-level tax savings. State income tax conformity to the federal tax code varies, and a handful of high-tax states have explicitly carved out §1202 from their conformity. California is the most consequential non-conforming state. California FTB conformity guidance states that California does not conform to §1202 (or §1045 rollover); QSBS gains are fully taxed at California's top 13.3 % rate (or 14.4 % including the additional Mental Health Services Tax surcharge for high earners). Pennsylvania, New Jersey, Alabama, Mississippi, and Wisconsin also do not fully conform to §1202. Massachusetts conforms partially (with its own caps and active-business interpretation). The remaining 30+ states with income taxes generally follow federal treatment — so QSBS gains are excluded for both federal and state income tax purposes.[23, 18, 17]

Practical implications for QSBS planning. First, residency at the time of sale is the dominant determinant of state tax exposure — not residency at the time of issuance. A founder who held QSBS as a Massachusetts resident for years but relocated to California months before sale faces California taxation on the entire gain (subject to California source rules and the still-active "exit tax" debates). Second, residency-change planning before sale is feasible but increasingly scrutinized; California in particular has become aggressive about challenging residency departures of high-net-worth individuals close to liquidity events, with FTB residency audits sometimes spanning multiple years and demanding extensive documentation of physical presence, primary domicile indicators, and business connections. Third, even within non-conforming states, married couples may benefit from filing strategies that allocate QSBS income to the spouse with the lower state-tax exposure (e.g., one spouse maintaining out-of-state residency).[23, 18]

QSBS Stacking: Gifting, Trusts, and Multi-Beneficiary Strategies

The §1202(b)(1) cap is a per-taxpayer, per-issuer limit. Each distinct taxpayer with respect to the same issuer gets their own $15 million cap (or 10× basis). This creates the central planning structure known as "QSBS stacking": multiplying the effective cap by transferring QSBS to multiple eligible taxpayers — typically a spouse, adult children, parents, and irrevocable non-grantor trusts (NGTs) for the benefit of those individuals. A founder with $50 million of unrealized QSBS gain can, with proper pre-sale planning, secure full §1202 exclusion across the entire $50 million by transferring portions to four or five separate taxpayers, each of whom gets their own $15 million cap. The key technical point is §1202(h): a gift of QSBS to another taxpayer carries with it the original holder's holding period and adjusted basis (basis tacking), and the recipient is treated as having acquired the stock by original issuance from the issuer for §1202 purposes.[1, 18, 20]

Three structural cautions. First — gift tax exposure. Transfers of high-FMV QSBS to family members or trusts are taxable gifts under §2501 unless they fit within the annual exclusion ($19,000 per donee in 2026 per IRS Rev. Proc. 2025-32) or the donor's lifetime estate-and-gift exemption ($15 million per individual after OBBBA permanently extended the higher exemption). For high-value QSBS transfers, the gift typically uses lifetime exemption rather than annual exclusion. Second — non-grantor trust structure matters. Only an irrevocable trust that is treated as a separate taxpayer for income tax purposes (a "non-grantor" trust) gets its own §1202 cap. Grantor trusts are treated as the same taxpayer as the grantor and do not multiply the cap. Third — anti-abuse rules. Reg §1.1202-2 contains anti-abuse provisions, and the IRS has signaled that aggressive last-minute stacking transfers immediately before a known liquidity event may be challenged as lacking substance. Best practice is to complete transfers well in advance of any specific anticipated sale.[1, 9, 18]

Eight Common QSBS Mistakes (and How OBBBA Magnifies Them)

Across thousands of QSBS engagements, the same eight failure modes recur. Mistake 1 — Holding stock in an LLC or S-corp instead of a C-corp. An LLC interest, even if economically equivalent to corporate stock, cannot be QSBS. Convert to C-corp before issuing any equity meant to be QSBS. Mistake 2 — Buying stock from existing shareholders rather than from the corporation directly. Secondary purchases on a tender offer or in a private sale do not satisfy the original-issuance requirement of §1202(c)(1)(B). Mistake 3 — Crossing the $75 million asset threshold in the wrong moment. Founders sometimes contribute large amounts of IP at C-corp formation that immediately push the corporation past the gross-asset threshold; pre-formation valuation work is essential. Mistake 4 — Selling at year three or four without considering §1045 rollover. The combination of partial 50%/75% exclusion plus §1045 rollover of the un-excluded portion can preserve far more wealth than an outright sale.[1, 2, 18]

Mistake 5 — Assuming the wash-sale rule applies to QSBS sales. The wash-sale rule of §1091 disallows losses on substantially identical securities repurchased within 30 days. §1202 transactions are about gains, not losses, and the wash-sale rule does not constrain QSBS gain-recognition strategies; however, a holder who incurred a loss on QSBS that did not qualify might still hit the wash-sale rule. Mistake 6 — Forgetting AMT impact for pre-OBBBA 50% and 75% exclusions. Pre-OBBBA, certain partial-exclusion regimes added 7 % of the excluded gain back as an AMT preference item under §57(a)(7). OBBBA Section 70431(d) repealed this AMT preference for stock acquired after July 4, 2025 — meaning post-OBBBA QSBS gains carry no AMT add-back. Pre-OBBBA QSBS still does. Mistake 7 — Ignoring state tax conformity. Covered in Section 8 above. Mistake 8 — Failing to report on Form 8949 with code "Q" and the exclusion as a negative in column (g). Many tax software packages require manual override to enter QSBS exclusions correctly; review IRS Form 8949 instructions closely.[11, 14, 18]

2026 Action Checklist: For Founders, Employees, and Investors

At Issuance. (1) Confirm the entity is a domestic C-corporation at the moment stock is issued — not an LLC, S-corp, or foreign entity. (2) Document the gross-asset value immediately before and immediately after issuance, with cash and FMV-of-property valuations preserved in the corporate minute book. (3) Verify the trade or business is not on the §1202(e)(3) exclusion list, and document the active-business intent. (4) For founder-share issuances at C-corp formation, file a Section 83(b) election within 30 days of issuance for any restricted stock. (5) Issue a "QSBS attestation letter" or board resolution memorializing that the stock satisfies §1202 at issuance — many institutional investors and acquirers ask for this in due diligence years later.[1, 7, 20]

During the Holding Period. (1) Annually obtain a tax-counsel or in-house attestation that the issuer continues to satisfy §1202 — particularly the 80 %-active-asset test and the qualified-trade test. (2) Monitor any pivots in business model that could push the company into an excluded trade. (3) For employees with stock options, exercise early when the strike-price-to-FMV spread is small, since the §1202 holding period runs from exercise for option-acquired stock, not from grant. (4) Keep meticulous documentation of cost basis (ESPP discount, exercise price, restricted stock vesting FMV) — Form 8949 reporting requires it. (5) For high-value positions, consider stacking transfers to family members or NGTs well in advance of any anticipated liquidity event.[1, 12, 18]

At Sale. (1) Confirm the holding period — three, four, or five years — by counting from issuance date (or option exercise date) to closing date. (2) Compute the per-issuer cap as the greater of $15 million or 10× basis. Track separately any cap usage from prior partial dispositions. (3) Determine the exclusion percentage (50, 75, or 100 %) and the resulting taxable §1202 gain (taxed at the 28 % federal rate plus 3.8 % NIIT for high earners). (4) Evaluate §1045 rollover if you are at year three or four and have lost conviction or want to redeploy. (5) Confirm state tax treatment for your residency at sale — California residents bear full state tax even on a 100 % federally-excluded gain. (6) Report on Form 8949 with code "Q" and the exclusion as a negative in column (g); aggregate to Schedule D and Form 1040 with detailed worksheet support. To project what the after-tax proceeds (federal-excluded plus state-taxed portions) compound to over a 30-year retirement horizon, run the math on our compound interest calculator.[1, 13, 15, 12]